Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

ClinicalTrials.gov ID: NCT00925600

Public ClinicalTrials.gov record NCT00925600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy

Study identification

NCT ID
NCT00925600
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
769 participants

Conditions and interventions

Interventions

  • Denosumab Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
30 Years to 120 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2009
Primary completion
May 11, 2016
Completion
May 11, 2016
Last update posted
May 29, 2017

2009 – 2016

United States locations

U.S. sites
52
U.S. states
24
U.S. cities
48
Facility City State ZIP Site status
Research Site Anaheim California 92801
Research Site Laguna Hills California 92653
Research Site Murrieta California 92562
Research Site San Diego California 92103
Research Site San Diego California 92120
Research Site San Diego California 92123
Research Site San Luis Obispo California 93405
Research Site Denver Colorado 80204
Research Site Denver Colorado 80211
Research Site Englewood Colorado 80113
Research Site Middlebury Connecticut 06762
Research Site New Britain Connecticut 06052
Research Site Trinity Florida 34655
Research Site Coeur d'Alene Idaho 83814
Research Site Greenwood Indiana 46143
Research Site West Des Moines Iowa 50266
Research Site Kansas City Kansas 66160
Research Site Shreveport Louisiana 71106
Research Site Annapolis Maryland 21401
Research Site Baltimore Maryland 21201
Research Site Greenbelt Maryland 20770
Research Site Grand Rapids Michigan 49546
Research Site Sartell Minnesota 56377
Research Site St Louis Missouri 63110
Research Site Missoula Montana 59808
Research Site Omaha Nebraska 68105-1850
Research Site Omaha Nebraska 68130
Research Site Berlin New Jersey 08009
Research Site Brick New Jersey 08724
Research Site Englewood New Jersey 07631
Research Site Lawrenceville New Jersey 08648
Research Site Mount Laurel New Jersey 08054
Research Site Albany New York 12208
Research Site Garden City New York 11530
Research Site Kingston New York 12401
Research Site New York New York 10021
Research Site Poughkeepsie New York 12601
Research Site Syracuse New York 13210
Research Site Gastonia North Carolina 28054
Research Site Greenville North Carolina 27834
Research Site Cincinnati Ohio 45212
Research Site Bala-Cynwyd Pennsylvania 19004
Research Site Lancaster Pennsylvania 17604
Research Site Philadelphia Pennsylvania 19107
Research Site Myrtle Beach South Carolina 29572
Research Site Knoxville Tennessee 37920
Research Site Austin Texas 78759
Research Site Dallas Texas 75231
Research Site San Antonio Texas 78229
Research Site Temple Texas 76508
Research Site Richmond Virginia 23235
Research Site Salem Virginia 24153

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 120 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00925600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00925600 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →